Innovo Therapeutics
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $22M
Investors
- 5
About Innovo Therapeutics
Based in Seoul, South Korea, and founded in 2019, Innovo Therapeutics Inc. is a drug research and development company that utilizes artificial intelligence to find new drugs to treat various inflammatory and immunological-related diseases. In January 2022, Innovo Therapeutics Inc. As of 2023, Innovo Therapeutics Inc. The firm researches and develops synthetic drugs targeting unmet medical needs in fibrosis, immune disorders, inflammatory diseases, and cancer. The firm’s key technology is DeepZema®, an artificial intelligence platform designed for drug candidate discovery and research efficiency. DeepZema® integrates machine learning for target discovery, and ADME/toxicity prediction, and combines existing DE Novo designs with docking to create and evaluate new structures. It is used for various stages of drug research, including ligand similarity and shape-based target identification, virtual screening, lead optimization, and ADME/toxicity calculations, providing real-time results through web interface.
Who invested in Innovo Therapeutics
5 investors across 2 rounds
See all investors in Innovo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Innovo Therapeutics
Who invested in Innovo Therapeutics?
Innovo Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Innovo Therapeutics raised?
Innovo Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Innovo Therapeutics last raise money?
Innovo Therapeutics's most recent round on record is a Series B, in Dec 2021.
What does Innovo Therapeutics do?
Based in Seoul, South Korea, and founded in 2019, Innovo Therapeutics Inc.
Where is Innovo Therapeutics headquartered?
Innovo Therapeutics is headquartered in Seoul, South Korea.
Which VCs invest in companies like Innovo Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Innovo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Innovo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.